Industry & Policy News

[The University of Queensland] Dr Kevin Koo, from The University of Queensland’s (UQ) Centre for Clinical Research, has been awarded one of five new research grants worth a combined value of $1.2 million from the Prostate Cancer Foundation of Australia.

[National Institute for Health and Care Research] A new Lancet Commission sets out recommendations to tackle urgent global challenges in breast cancer. Supported by the National Institute for Health and Care Research, the commission reveals that despite significant improvements inequities persist.

[Fierce Biotech] Europe launched the most clinical trials for cystic fibrosis treatments, while North America leads in those for acute myeloid leukemia, according to a pair of new global trial landscape reports announced by contract research organization Novotech. Global venture funding for R&D on treatments for both diseases topped $1 billion each over the past five years.

[Brain Tomorrow] A new development, termed fetal brain organoids or FeBOs, offers an unprecedented opportunity to study the intricate processes of early brain development. However, it also raises complex ethical and legal questions that demand careful consideration.

[SCG Cell Therapy] SCG Cell Therapy and the Agency for Science, Technology and Research (A*STAR) announced the launch of joint laboratories for cellular immunotherapies. This collaboration,aims to advance the development of iPSC technology to produce novel cell therapies that meet GMP standards.

[University of Waterloo] Canada will not reach the original World Health Organization's (WHO) target of eliminating the Hepatitis C virus by 2030 and lags in comparison to other developed countries, a new study led by researchers at the University of Waterloo has found.